Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics

NCT03643289 is registered in ClinicalTrials.gov with East and North Hertfordshire NHS Trust as lead sponsor.

NCT NCT03643289
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03643289 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Response to Immunotherapy for Melanoma With Gut Microbiome and Metabolomics
Lead sponsor
East and North Hertfordshire NHS Trust
Phase
Observational
Overall status
Unknown status
Start date
April 4, 2018
Completion date
May 2, 2023
Enrollment
450 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

melanoma (skin)